发明名称 |
Bacteriophage gene 3 protein compositions and use as amyloid binding agents |
摘要 |
The invention relates to agents and to pharmaceutical compositions for reducing the formation of amyloid and/or for promoting the disaggregation of amyloid proteins. The compositions may also be used to detect amyloid. |
申请公布号 |
US9493515(B2) |
申请公布日期 |
2016.11.15 |
申请号 |
US201214361157 |
申请日期 |
2012.11.28 |
申请人 |
PROCLARA BIOSCIENCES, INC. |
发明人 |
Krishnan Rajaraman;Fisher Richard |
分类号 |
A61K51/10;C07K16/00;C07K14/24;C07K14/005;A61K38/16;A61K47/48;B82Y5/00;C12N7/00;A61K38/00 |
主分类号 |
A61K51/10 |
代理机构 |
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP |
代理人 |
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP |
主权项 |
1. A pharmaceutical composition comprising a fusion protein that comprises an amyloid-binding polypeptide and an immunoglobulin IgG constant region,
wherein the amyloid binding polypeptide is present in an amount sufficient to treat a disease or disorder associated with misfolded and/or aggregated amyloid protein and a pharmaceutically acceptable carrier, and wherein the polypeptide comprises at least one of:
(a) a wild type g3p;(b) an amyloid-binding fragment of wild type g3p; or(c) a mutant of (a) or (b) that retains the ability to bind to amyloid. |
地址 |
Cambridge MA US |